ALYSSA ALVAREZ: Open Payments
NPI 1396273306 · ORMOND BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,470 in 66 payments from 27 companies in 2025. Trend: 2023 $2,503 · 2024 $3,701 · 2025 $1,470
Food & beverage: $1,470
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $149 |
| ABBVIE INC. | 8 | $137 |
| UCB, Inc. | 4 | $133 |
| Otsuka America Pharmaceutical, Inc. | 4 | $93 |
| Amneal Pharmaceuticals LLC | 4 | $77 |
| MDD US Operations, LLC | 3 | $73 |
| PFIZER INC. | 4 | $73 |
| Vanda Pharmaceuticals Inc. | 3 | $70 |
| SK Life Science, Inc. | 2 | $62 |
| Eisai Inc. | 2 | $57 |
Products named: KESIMPTA, Briviact, REXULTI, QULIPTA, Leqembi, CREXONT, Gocovri, PONVORY.
Industry payments across FL — which companies pay providers there.
